Nasdaq smmt.

Oxford, UK, and Cambridge, MA, US, 3 October 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) today announced that it presented results from the Phase 2 clinical trial of ridinilazole in ...Check if SMMT Stock has a Buy or Sell Evaluation. SMMT Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Summit Therapeutics plc News.Nov 30, 2023 · The latest price target for Summit Therapeutics ( NASDAQ: SMMT) was reported by HC Wainwright & Co. on Wednesday, November 18, 2020. The analyst firm set a price target for 0.00 expecting SMMT to ... Oxford, UK, and Cambridge, MA, US, 6 February 2020 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) today announced that it achieved the first milestone under its license and collaboration ...Summit Therapeutics Inc (NASDAQ:SMMT) announced that the FDA disagrees with its proposed change to the primary endpoint in Phase 3 Ri-CoDIFy studies.; In a regulatory filing, the Company said that ...

Nasdaq Listed DATA AS OF Nov 26, 2021 0 Add to Watchlist Add to Portfolio SMMT SMMT HISTORICAL DATA SMMT Historical Data ... Back to SMMT Overview Get up to 10 …Summit Therapeutics Plc operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company operates through the Drug Development segment, which covers its research and development activities carried out by the Group. Summit Therapeutics was founded by Stephen Graham Davies and ...Summit Therapeutics Inc. (NASDAQ:SMMT – Get Free Report)’s stock price dropped 3.9% during trading on Friday . The stock traded as low as $1.94 and last traded at $1.95. Approximately 87,078 shares traded hands during trading, a decline of 95% from the average daily volume of 1,810,309 shares. The stock had previously closed at $2.03. […]

Bitdeer Technologies Holding Co (NASDAQ:BTDR)’s Major holders Insiders own 59.14% of the company shares, while shares held by institutions stand at 2.18% with a share float percentage of 5.33%. Investors are also buoyed by the number of investors in a company, with Bitdeer Technologies Holding Co having a total of 13 institutions that hold ...

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...WebMay 11, 2023 · Summit Therapeutics Inc. (NASDAQ:SMMT) is a biotechnology company that focuses on developing treatments to target infectious diseases. The firm is headquartered in Cambridge, Massachusetts. Nov 8, 2023 · The public float for SMMT is 111.75M, and currently, short sellers hold a 9.57% ratio of that floaft. The average trading volume of SMMT on November 08, 2023 was 1.02M shares. SMMT) stock’s latest price update. Summit Therapeutics Inc (NASDAQ: SMMT)’s stock price has plunge by -12.16relation to previous closing price of 2.18. Dec 6, 2022 · Cambridge, Massachusetts-based biotech Summit Therapeutics (NASDAQ:SMMT) jumped ~38% pre-market Tuesday after announcing a collaboration and license agreement with Hong Kong-listed biopharma Akeso ... 30 de jul. de 2014 ... NASDAQ:SMMT. share_price_up350_53d8a4c7a8864. Shares in drug discovery firm Summit (LON:SUMM) advanced early on Wednesday as it emerged chief ...

há 2 dias ... (NASDAQ:SMMT – Get Free Report)'s stock price dropped 3.9% during trading on Friday . The stock traded as low as $1.94 and last traded at ...

Nov 3, 2021 · Follow. Cambridge, Massachusetts, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that Dr. Urte Gayko, PhD, has been appointed to our Board of Directors ...

Summit Therapeutics Inc. (NASDAQ:SMMT) issued its earnings results on Monday, November, 15th. The company reported ($0.20) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.29) by $0.09. The firm earned $6.12 million during the quarter.Nov 8, 2023 · Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2023 Earnings Call Transcript 11 Stocks with Heavy Insider Buying in 2023 Summit Therapeutics Inc. (NASDAQ:SMMT) Q4 2022 Earnings Call Transcript 25 ... Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Cambridge, Massachusetts, and we have additional offices in Oxford, UK ...OXFORD, United Kingdom, March 07, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM) announces it has opened enrolment in a planned additional group in its Phase 2 open ...Cambridge, MA, Oct. 08, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that Kenneth A. Clark, JD, has been appointed to our Board of Directors, effective immediately.Web

The Society of Motor Manufacturers & Traders (SMMT) supports and promotes the interests of the UK automotive industry at home and abroad.Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter …78% of the company is held by a single shareholder (Robert Duggan) Insiders have been buying lately. If you want to know who really controls Summit Therapeutics Inc. ( NASDAQ:SMMT ), then you'll ...WebTrack Summit Therapeutics Inc (SMMT) Stock Price, Quote, latest community messages, chart, news and other stock related information.View the latest Summit Therapeutics Inc. (SMMT) stock price, news, historical charts, analyst ratings and financial information from WSJ.Nov 3, 2021 · Follow. Cambridge, Massachusetts, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that Dr. Urte Gayko, PhD, has been appointed to our Board of Directors ... Find the latest news headlines from Summit Therapeutics Inc. Common Stock (SMMT) at Nasdaq.com.

há 2 dias ... (NASDAQ:SMMT – Get Free Report)'s stock price dropped 3.9% during trading on Friday . The stock traded as low as $1.94 and last traded at ...Fiscal Q3 2023 ended 9/30/23. Reported on 11/7/23. Get the latest Summit Therapeutics Inc (SMMT) real-time quote, historical performance, charts, and other financial information to help you make...

Nov 3, 2021 · Follow. Cambridge, Massachusetts, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that Dr. Urte Gayko, PhD, has been appointed to our Board of Directors ... Source: Kantar Media. View the latest Summit Therapeutics Inc. (SMMT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Summit Therapeutics, Inc. (NASDAQ:SMMT) Q1 2023 Earnings Conference Call May 11, 2023 9:00 AM ET. Company Participants. Dave Gancarz - SVP, Stakeholder Relations, Business Development & Corporate ...CEO. Website. 2003. 77. Bob Duggan. https://www.summittxinc.com. Summit Therapeutics Inc., a biopharmaceutical company, research and develops primarily …CAMBRIDGE, Mass. and OXFORD, United Kingdom, Oct. 04, 2016 (GLOBE NEWSWIRE) -- Sarepta Therapeutics (NASDAQ:SRPT) and Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM) today announced that they ...CEO. Website. 2003. 77. Bob Duggan. https://www.summittxinc.com. Summit Therapeutics Inc., a biopharmaceutical company, research and develops primarily …OXFORD, United Kingdom, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM) the drug discovery and development company advancing therapies for Duchenne muscular ...

Summit Therapeutics, Inc. (NASDAQ:SMMT) Q1 2023 Earnings Conference Call May 11, 2023 9:00 AM ET. Company Participants. Dave Gancarz - SVP, Stakeholder Relations, Business Development & Corporate ...

OXFORD, United Kingdom, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for rare diseases and ...

Summit Therapeutics PLC (NASDAQ:SMMT)’s CEO Robert Duggan also bought a 376 million shares of the company during the same month at $1.05 per share. As of May 19, the stock is trading at $1.62.Source: Kantar Media. View the latest Summit Therapeutics Inc. (SMMT) stock price, news, historical charts, analyst ratings and financial information from WSJ.See the latest Summit Therapeutics Inc Ordinary Shares stock price (SMMT:XNAS), related news, valuation, dividends and more to help you make your investing decisions.During the recent session, Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares were 1.08 million, with the beta value of the company hitting -1.02. At the last check today, the stock’s price was $1.65, reflecting an intraday loss of -9.32% or -$0.18. The 52-week high for the SMMT share is $5.há 3 dias ... Home SMMT • NASDAQ. add. Share. Summit Therapeutics Inc. $2.13. After ... NASDAQ. Market news. The Times of Israel. 2 hours ago. Israel-based ...CEO. Website. 2003. 77. Bob Duggan. https://www.summittxinc.com. Summit Therapeutics Inc., a biopharmaceutical company, research and develops primarily oncology therapies in the United States, and the United Kingdom. The company’s product pipeline includes SMT-738, a novel class of precision antibiotics for treatment which is in preclinical ...Cambridge, Massachusetts, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on ...Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced that the Company’s Board of Directors has set the record date for the Company’s previously announced rights offering, which will be available to all holders of record of the Company’s common stock, par value $0.01 (the “Common Stock”), as of the close of the market on February 6, 2023 (the ...Conference Call to be Held at 9:00am ET. MENLO PARK, Calif.--(BUSINESS WIRE)-- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) will host an earnings call to ...Cambridge, MA, November 23, 2020 – Summit Therapeutics Inc. (NASDAQ: SMMT) announces that Dr. Mahkam “Maky” Zanganeh, DDS, MBA, has been appointed as Chief Operating Officer, effective ...

May 5, 2023 · Shares of Summit Therapeutics ( SMMT 4.93%) were up by 61.4% for the week as of late Friday afternoon, according to data provided by S&P Global Market Intelligence. The healthcare stock, which ... View live Summit Therapeutics Inc. chart to track its stock's price action. Find market predictions, SMMT financials and market news.Cambridge, MA, June 08, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) is set to join the broad-market Russell 3000® Index at the conclusion of the 2021 Russell indexes annual ...Instagram:https://instagram. banks with best appsry'gold coin purchase from bankstocks biggest losers today Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript. The binding of PD-1 increases VEGF by fourfold, and the binding of VEGF increases PD-1 binding by 18-fold. And so ... nvax news and rumorsgood industries to invest in há 3 dias ... Home SMMT • NASDAQ. add. Share. Summit Therapeutics Inc. $2.13. After ... NASDAQ. Market news. The Times of Israel. 2 hours ago. Israel-based ... lvs stocks Nov 28, 2023 · Stock analysis for Summit Therapeutics Inc (SMMT:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. In the last year, multiple insiders have substantially increased their holdings of Summit Therapeutics Inc. (NASDAQ:SMMT) stock, indicating that insiders' optimism about the company's prospects ...11 de mai. de 2023 ... (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on operational progress for the ...